Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 12 studies | 26% ± 9% | |
non-classical monocyte | 7 studies | 28% ± 15% | |
myeloid cell | 7 studies | 25% ± 6% | |
microglial cell | 7 studies | 28% ± 10% | |
classical monocyte | 6 studies | 30% ± 14% | |
astrocyte | 6 studies | 25% ± 8% | |
monocyte | 5 studies | 28% ± 10% | |
dendritic cell | 3 studies | 32% ± 19% | |
epithelial cell | 3 studies | 36% ± 9% | |
GABAergic neuron | 3 studies | 35% ± 9% | |
glutamatergic neuron | 3 studies | 36% ± 10% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 25% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 1604.98 | 178 / 180 | 100% | 20.21 | 430 / 430 |
intestine | 100% | 2359.72 | 966 / 966 | 99% | 11.18 | 521 / 527 |
lung | 100% | 4021.37 | 578 / 578 | 99% | 13.76 | 1140 / 1155 |
breast | 100% | 3136.58 | 459 / 459 | 98% | 14.18 | 1094 / 1118 |
brain | 98% | 1379.45 | 2589 / 2642 | 100% | 12.49 | 704 / 705 |
uterus | 100% | 2033.91 | 170 / 170 | 96% | 15.95 | 440 / 459 |
thymus | 100% | 2117.04 | 651 / 653 | 96% | 10.28 | 578 / 605 |
stomach | 97% | 1425.13 | 347 / 359 | 98% | 10.36 | 280 / 286 |
prostate | 100% | 1888.79 | 245 / 245 | 92% | 7.25 | 463 / 502 |
bladder | 100% | 1957.86 | 21 / 21 | 92% | 11.38 | 462 / 504 |
esophagus | 100% | 2139.62 | 1445 / 1445 | 90% | 8.35 | 164 / 183 |
adrenal gland | 99% | 1341.09 | 256 / 258 | 90% | 10.30 | 206 / 230 |
skin | 100% | 3087.06 | 1808 / 1809 | 85% | 6.82 | 401 / 472 |
kidney | 97% | 1379.10 | 86 / 89 | 84% | 9.41 | 760 / 901 |
pancreas | 82% | 699.28 | 268 / 328 | 98% | 16.02 | 175 / 178 |
liver | 90% | 887.34 | 204 / 226 | 66% | 4.48 | 268 / 406 |
adipose | 100% | 4081.52 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 16.65 | 29 / 29 |
spleen | 100% | 5615.44 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 12.49 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.61 | 1 / 1 |
blood vessel | 100% | 2135.59 | 1330 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1919.48 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 3352.21 | 907 / 929 | 0% | 0 | 0 / 0 |
muscle | 94% | 1155.21 | 753 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 68% | 3.51 | 54 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006338 | Biological process | chromatin remodeling |
GO_0045444 | Biological process | fat cell differentiation |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001227 | Molecular function | DNA-binding transcription repressor activity, RNA polymerase II-specific |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0003682 | Molecular function | chromatin binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0043522 | Molecular function | leucine zipper domain binding |
GO_0140713 | Molecular function | histone chaperone activity |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0035497 | Molecular function | cAMP response element binding |
GO_0005515 | Molecular function | protein binding |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | JDP2 |
Protein name | Jun dimerization protein 2 |
Synonyms | |
Description | FUNCTION: Component of the AP-1 transcription factor that represses transactivation mediated by the Jun family of proteins. Involved in a variety of transcriptional responses associated with AP-1 such as UV-induced apoptosis, cell differentiation, tumorigenesis and antitumogeneris. Can also function as a repressor by recruiting histone deacetylase 3/HDAC3 to the promoter region of JUN. May control transcription via direct regulation of the modification of histones and the assembly of chromatin. . |
Accessions | ENST00000435893.6 [Q8WYK2-1] ENST00000651602.1 [Q8WYK2-1] ENST00000267569.5 [Q8WYK2-2] ENST00000559060.5 ENST00000419727.6 [Q8WYK2-1] H0YKE4 Q8WYK2 ENST00000437176.5 [Q8WYK2-1] |